LoginSignup
M1 Kliniken logo

M1 Kliniken

Stock
Stock
ISIN: DE000A0STSQ8
Ticker: M12
DE000A0STSQ8
M12

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

M1 Kliniken has so far distributed $1.366 in 2026. The next dividend will be paid on 13.07.2027

$0.656

CHART BY

Frequently asked questions

The market capitalization of M1 Kliniken is 393.37M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for M1 Kliniken is 19.51. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
M1 Kliniken's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.087. EPS indicates the company's profitability on a per-share basis.
Currently, 1 analysts cover M1 Kliniken's stock, with a consensus target price of 30.00. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, M1 Kliniken reported a revenue of 257.36M.
M1 Kliniken's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is 36.64M. EBITDA measures the company's overall financial performance.
M1 Kliniken has a free cash flow of 23.08M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
The free float of M1 Kliniken is 6.25M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
393.37M
EPS (TTM) 
$1.087
Free Float 
6.25M
P/E ratio (TTM) 
19.51
Revenue (TTM) 
257.36M
EBITDA (TTM) 
36.64M
Free Cashflow (TTM) 
23.08M

Pricing

1D span
$23.86$24.79
52W span
$15.73$25.19

Analyst Ratings

The price target is 30.00 and the stock is covered by 1 analysts.

Buy

1

Hold

0

Sell

0

Information

M1 Kliniken AG engages in the provision of medical services in the field of beauty sector. It operates through the Beauty and Trade segments. The Beauty segment focuses on medical-aesthetic beauty treatments and operations as well as the operation and provision of medical infrastructures for partner companies. The Trade segment sells pharmaceuticals and medical products in the cost-intensive therapeutic areas of oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine. The company was founded in 2007 and is headquartered in Berlin, Germany.

Industries
Medical/ Nursing Services
Sector
Health Care

Identifier

ISIN
DE000A0STSQ8
Primary Ticker
M12

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin